Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Stock Option Activities) (Details)

v3.24.1.1.u2
Stockholders' Equity (Stock Option Activities) (Details) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]    
Options vested and expected to vest, Number of shares 18,896  
Number of shares, Granted 540,000  
Options vested and expected to vest, Number of shares 558,896 18,896
Options vested and exercisable, Number of shares 18,896  
Options vested and expected to vest, Weighted average exercise price $ 20.55  
Weighted average exercise price, Granted 1.68  
Options vested and expected to vest, Weighted average exercise price 2.32 $ 20.55
Options vested and exercisable, Weighted average exercise price $ 20.55  
Total weighted average intrinsic value, Granted $ 216,000  
Total weighted average intrinsic value, Options vested and expected to vest $ 216,000  
Options vested and expected to vest, Weighted average contractual life 6 years 9 months 7 days 1 year 9 months 3 days
Options Granted, weighted average remaining contractual life (years) 3 years 9 months 18 days  
Options vested and exercisable, Weighted average remaining contractual life (years) 1 year 9 months 3 days